About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Sweden-Based Drug Firm to Acquire a Majority Stake in Nitin Lifesciences for Rs 671.2 Crore

by Reshma Anand on October 20, 2015 at 6:08 PM
Font : A-A+

Sweden-Based Drug Firm to Acquire a Majority Stake in Nitin Lifesciences for Rs 671.2 Crore

Recipharm has entered into an agreement to acquire a majority stake in Nitin Lifesciences Ltd, a sterile injectable company for an estimated Rs 671.2 crore.

"Recipharm will acquire 74 percent of the shares of Nitin Lifesciences for an estimated purchase consideration of Rs 671.2 crore on a cash and debt free basis. The acquisition is expected to be completed in Q1 of 2016 once FIPB approval comes through," said Recipharm.

Advertisement

Recipharm CEO Thomas Eldered said: "It is our stated aim to have a more global footprint and participate in opportunities that emerging markets bring. The Indian market is particularly attractive showing high growth levels, and the transaction firmly establishes Recipharm's EM strategy. Nitin Lifesciences can also be used as a platform for entry into other regions."

"We believe that with the support and network of Recipharm, we shall be able to further expand and continue to grow both domestically and outside the Indian market," said Chetan Sobti, Nitin Lifesciences CEO.
Advertisement

"Recipharm after a certain point will have the option to acquire the remaining shares in Nitin, and current owners will have the option to sell to Recipharm their remaining shares in Nitin," the company said.

Recipharm is a leading CDMO (contract development and manufacturing organization) in the pharmaceutical industry based in Sweden employing some 2,200 employees. The company will finance the acquisition under the existing bank credit facilities, said the Sweden-based firm. 

Source: PTI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Amyotrophic Lateral Sclerosis (ALS) 

Most Popular on Medindia

Turmeric Powder - Health Benefits, Uses & Side Effects Diaphragmatic Hernia Indian Medical Journals Accident and Trauma Care Hearing Loss Calculator Calculate Ideal Weight for Infants Daily Calorie Requirements Iron Intake Calculator Selfie Addiction Calculator Blood Donation - Recipients
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Sweden-Based Drug Firm to Acquire a Majority Stake in Nitin Lifesciences for Rs 671.2 Crore Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests